Wolfe Research analyst Kalpit Patel reiterated a Peerperform rating on ORIC Pharmaceuticals (NASDAQ: ORIC).The analyst comments "This morning, Ipsen (not ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE